The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma

Abstract

cells and normal skin cells. Furthermore, Curaderm is highly specific and is capable of causing cancer cell death by the orderly process of apoptosis. The clinical aspects of Curaderm pharmacotherapy have amply been described in the literature. Recently, a thought-provoking article “Curaderm, the long-awaited breakthrough for basal cell carcinoma” was published. Although the article is awe-inspiring, it does not address the mechanisms and mode of actions of Curaderm that achieve such remarkable clinical outcomes. This communication centres on the pharmacological mechanisms, which establish that Curaderm is indeed both selective and specific in eliminating basal cell carcinoma from the skin.